bradanicline code name drug developed targacept acts partial agonist subtype neural nicotinic acetylcholine receptors showed cognitive enhancing effects animal studies developed collaboration targacept astrazeneca potential treatment schizophrenia attention deficit phase clinical trials completed successfully phase ii may astrazeneca declined exercise right license september targacept ended development badanicline purpose treating adhd studied cognitive memory bradanicline discontinued alzheimers disease cognitive impairment schizophrenia also discontinued drug article relating nervous system stub help wikipedia expanding httpsenwikipediaorgwikibradanicline